Guggenheim Maintains Buy on Zura Bio, Lowers Price Target to $8
Benzinga Newsdesk 41 minutes ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Yatin Suneja maintains Zura Bio (NASDAQ:ZURA) with a Buy and lowers the price target from $20 to $8.
Guggenheim analyst Yatin Suneja maintains Zura Bio (NASDAQ:ZURA) with a Buy and lowers the price target from $20 to $8.